Skip to main content
SpringerLink
Log in

Prostate Cancer Among Asian Americans

  • Chapter
  • First Online:
Cancer Epidemiology Among Asian Americans

  • 446 Accesses

Abstract

Prostate cancer, the most commonly diagnosed cancers in men, is a clinically heterogeneous disease. Some tumors remain indolent with little impact on morbidity and survival, while others are aggressive and rapidly progress to advanced and lethal disease. Studies of prostate cancer incidence have shown considerably higher incidence rates among Asian-American men living in the United States (US) relative to Asian men living in Asian countries. Although differences in screening practices by prostate-specific antigen (PSA) testing likely account for some of the differences in incidence, the adoption of Western lifestyles with migration to the US may play a role and involve the interplay between genetic and environmental factors. Epidemiological studies have examined migration-related risk factors among Asian Americans, capitalizing on the unique heterogeneity of specific Asian populations by generational status and acculturation. Age, race/ethnicity, family history, and genetic susceptibility are established risk factors for prostate cancer. Additional risk factors that have been implicated include hormonal and infection/inflammatory factors, body mass index, diabetes, physical activity, smoking, and dietary intake of animal and polyunsaturated fat, soy products, and green tea. In this chapter, we summarize our current understanding of the epidemiology of prostate cancer in Asian-American populations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bell KJ, Del Mar C, Wright G, Dickinson J, Glasziou P (2015) Prevalence of incidental prostate cancer: a systematic review of autopsy studies. Int J Cancer 137(7):1749–1757. doi:10.1002/ijc.29538

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2016) SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2013, based on November 2015 SEER data submission, posted to the SEER web site, April 2016

  3. Gomez SL, Noone AM, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, Morris C, Kwong S, Fish K, Wilkens LR, Goodman MT, Deapen D, Miller BA (2013) Cancer incidence trends among Asian American populations in the United States, 1990–2008. J Natl Cancer Inst 105(15):1096–1110. doi:10.1093/jnci/djt157, djt157 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  4. Welch HG, Albertsen PC (2009) Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst 101(19):1325–1329. doi:10.1093/jnci/djp278, djp278 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, Henley SJ, Eheman CR, Anderson RN, Penberthy L (2015) Annual Report to the Nation on the Status of Cancer, 1975–2011. Featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 107(6):djv048. doi:10.1093/jnci/djv048, djv048 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  6. Magi-Galluzzi C, Tsusuki T, Elson P, Simmerman K, LaFargue C, Esgueva R, Klein E, Rubin MA, Zhou M (2011) TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African–American and Japanese patients. Prostate 71(5):489–497. doi:10.1002/pros.21265

    Article  CAS  PubMed  Google Scholar 

  7. Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC, Hoffman KE, Sweeney CJ, Beard CJ, D’Amico AV, Martin NE, Kim SP, Trinh QD, Nguyen PL (2014) Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer. Clin Genitourin Cancer 12(5):e189–e195. doi:10.1016/j.clgc.2014.04.003, S1558-7673(14)00081-0 [pii]

    Article  PubMed  Google Scholar 

  8. Trinh QD, Nguyen PL, Leow JJ, Dalela D, Chao GF, Mahal BA, Nayak M, Schmid M, Choueiri TK, Aizer AA (2015) Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment. J Natl Cancer Inst 107(6):djv054. doi:10.1093/jnci/djv054, djv054 [pii]

    Article  PubMed  Google Scholar 

  9. Fedewa SA, Etzioni R, Flanders WD, Jemal A, Ward EM (2010) Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004–2006. Cancer Epidemiol Biomarkers Prev 19(10):2437–2444. doi:10.1158/1055-9965.EPI-10-0299, 1055-9965.EPI-10-0299 [pii]

    Article  PubMed  Google Scholar 

  10. Man A, Pickles T, Chi KN (2003) Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer. J Urol 170(3):901–904. doi:10.1097/01.ju.0000081423.37043.b4, S0022-5347(05)63259-4 [pii]

    Article  PubMed  Google Scholar 

  11. Raymundo EM, Rice KR, Chen Y, Zhao J, Brassell SA (2011) Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system. BJU Int 107(8):1216–1222. doi:10.1111/j.1464-410X.2010.09685.x

    Article  PubMed  Google Scholar 

  12. Robbins AS, Koppie TM, Gomez SL, Parikh-Patel A, Mills PK (2007) Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995–2004. Cancer 110(6):1255–1263. doi:10.1002/cncr.22872

    Article  PubMed  Google Scholar 

  13. Lichtensztajn DY, Gomez SL, Sieh W, Chung BI, Cheng I, Brooks JD (2014) Prostate cancer risk profiles of Asian–American men: disentangling the effects of immigration status and race/ethnicity. J Urol 191(4):952–956. doi:10.1016/j.juro.2013.10.075, S0022-5347(13)05758-3 [pii]

    Article  PubMed  Google Scholar 

  14. U.S. Preventive Services Task Force (2008) Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149(3):185–191, 149/3/185 [pii]

    Article  Google Scholar 

  15. Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P (2010) Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 14;341:c4543. doi:10.1136/bmj.c4543

    Google Scholar 

  16. Moyer VA (2012) Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157(2):120–134. doi:10.7326/0003-4819-157-2-201207170-00459, 1216568 [pii]

    Article  PubMed  Google Scholar 

  17. UCLA Center for Health Policy Research. AskCHIS 2009. PSA Screening among adult males (California). http://ask.chis.ucla.edu. Accessed 4 Aug 2015

  18. Lee SY (2015) Cultural factors associated with breast and cervical cancer screening in Korean American women in the US: an integrative literature review. Asian Nurs Res 9(2):81–90. doi:10.1016/j.anr.2015.05.003, S1976-1317(15)00036-5 [pii]

    Article  Google Scholar 

  19. Lee-Lin F, Menon U, Pett M, Nail L, Lee S, Mooney K (2007) Breast cancer beliefs and mammography screening practices among Chinese American immigrants. J Obstet Gynecol Neonatal Nurs 36(3):212–221. doi:10.1111/j.1552-6909.2007.00141.x, JOGN141 [pii]

    Article  PubMed  Google Scholar 

  20. Poonawalla IB, Goyal S, Mehrotra N, Allicock M, Balasubramanian BA (2014) Attitudes of South Asian women to breast health and breast cancer screening: findings from a community based sample in the United States. Asian Pac J Cancer Prev 15(20):8719–8724

    Article  PubMed  Google Scholar 

  21. Wu TY, West B, Chen YW, Hergert C (2006) Health beliefs and practices related to breast cancer screening in Filipino, Chinese and Asian–Indian women. Cancer Detect Prev 30(1):58–66. doi:10.1016/j.cdp.2005.06.013, S0361-090X(05)00095-4 [pii]

    Article  PubMed  Google Scholar 

  22. Harmon BE, Little MA, Woekel ED, Ettienne R, Long CR, Wilkens LR, Le Marchand L, Henderson BE, Kolonel LN, Maskarinec G (2014) Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort. Cancer Epidemiol 38(2):162–167. doi:10.1016/j.canep.2014.02.007, S1877-7821(14)00029-0 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  23. May FP, Almario CV, Ponce N, Spiegel BM (2015) Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening. Am J Gastroenterol 110(10):1388–1394. doi:10.1038/ajg.2015.138, ajg2015138 [pii]

    Article  PubMed  Google Scholar 

  24. Thompson CA, Gomez SL, Chan A, Chan JK, McClellan SR, Chung S, Olson C, Nimbal V, Palaniappan LP (2014) Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans. Cancer Epidemiol Biomarkers Prev 23(11):2208–2217. doi:10.1158/1055-9965.EPI-14-0487, 23/11/2208 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bao Y, Fox SA, Escarce JJ (2007) Socioeconomic and racial/ethnic differences in the discussion of cancer screening: “between-” versus “within-” physician differences. Health Serv Res 42(3 Pt 1):950–970. doi:10.1111/j.1475-6773.2006.00638.x, HESR638 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  26. Conde FA, Landier W, Ishida D, Bell R, Cuaresma CF, Misola J (2011) Barriers and facilitators of prostate cancer screening among Filipino men in Hawaii. Oncol Nurs Forum 38(2):227–233. doi:10.1188/11.ONF.227-233, JG51R3X46013V673 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  27. Glenn BA, Bastani R, Maxwell AE, Mojica CM, Herrmann AK, Gallardo NV, Swanson KA, Chang LC (2012) Prostate cancer screening among ethnically diverse first-degree relatives of prostate cancer cases. Health Psychol 31(5):562–570. doi:10.1037/a0028626, 2012-16094-001 [pii]

    Article  PubMed  Google Scholar 

  28. Lee HY, Jung Y (2013) Older Korean American men’s prostate cancer screening behavior: the prime role of culture. J Immigr Minor Health 15(6):1030–1037. doi:10.1007/s10903-013-9804-x

    Article  PubMed  Google Scholar 

  29. Seo HS, Lee NK (2010) Predictors of PSA screening among men over 40 years of age who had ever heard about PSA. Korean J Urol 51(6):391–397. doi:10.4111/kju.2010.51.6.391

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kolonel LN, Wilkens LR (2006) Migrant studies. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York

    Google Scholar 

  31. Parkin DM, Khlat M (1996) Studies of cancer in migrants: rationale and methodology. Eur J Cancer 32A(5):761–771

    Article  CAS  PubMed  Google Scholar 

  32. Thomas DB, Karagas MR (1996) Migrant studies. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 2nd edn. Oxford University Press, Oxford

    Google Scholar 

  33. Ito K (2014) Prostate cancer in Asian men. Nat Rev Urol 11(4):197–212. doi:10.1038/nrurol.2014.42, nrurol.2014.42 [pii]

    Article  PubMed  Google Scholar 

  34. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, M. Heanue, Boyle P (eds). (2007) Cancer Incidence in Five Continents Volume IX. International Agency for Research on Cancer. Lyon, France, http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/. Accessed Aug 2015

  35. Severson RK, Nomura AM, Grove JS, Stemmermann GN (1989) A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49(7):1857–1860

    CAS  PubMed  Google Scholar 

  36. Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME, Nagamine FS (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 151(4):346–357

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW et al (1995) Prostate cancer in relation to diet, physical activity, and body size in Blacks, Whites, and Asians in the United States and Canada. J Natl Cancer Inst 87(9):652–661

    Article  CAS  PubMed  Google Scholar 

  38. Cook PJ, Doll R, Fellingham SA (1969) A mathematical model for the age distribution of cancer in man. Int J Cancer 4(1):93–112

    Article  CAS  PubMed  Google Scholar 

  39. Hsing AW, Tsao L, Devesa SS (2000) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85(1):60–67. doi:10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B [pii]

    Article  CAS  PubMed  Google Scholar 

  40. Brawley OW, Knopf K, Thompson I (1998) The epidemiology of prostate cancer part II: the risk factors. Semin Urol Oncol 16(4):193–201

    CAS  PubMed  Google Scholar 

  41. Hoffmann TJ, Van Den Eeden SK, Sakoda LC, Jorgenson E, Habel LA, Graff RE, Passarelli MN, Cario CL, Emami NC, Chao CR, Ghai NR, Shan J, Ranatunga DK, Quesenberry CP, Aaronson D, Presti J, Wang Z, Berndt SI, Chanock SJ, McDonnell SK, French AJ, Schaid DJ, Thibodeau SN, Li Q, Freedman ML, Penney KL, Mucci LA, Haiman CA, Henderson BE, Seminara D, Kvale MN, Kwok PY, Schaefer C, Risch N, Witte JS (2015) A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov 5(8):878–891. doi:10.1158/2159-8290.CD-15-0315, 2159-8290.CD-15-0315 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Liu JH, Li HW, Tong M, Li M, Na YQ (2004) Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer. Zhonghua Yi Xue Za Zhi 84(5):364–368

    CAS  PubMed  Google Scholar 

  43. Han Y, Hazelett DJ, Wiklund F, Schumacher FR, Stram DO, Berndt SI, Wang Z, Rand KA, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Xu J, Travis RC, Key TJ, Siddiq A, Canzian F, Takahashi A, Kubo M, Stanford JL, Kolb S, Gapstur SM, Diver WR, Stevens VL, Strom SS, Pettaway CA, Al Olama AA, Kote-Jarai Z, Eeles RA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Isaacs WB, Chen C, Lindstrom S, Le Marchand L, Giovannucci EL, Pomerantz M, Long H, Li F, Ma J, Stampfer M, John EM, Ingles SA, Kittles RA, Murphy AB, Blot WJ, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske MC, Wu SY, Hennis AJ, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Witte JS, Casey G, Riboli E, Li Q, Freedman ML, Hunter DJ, Gronberg H, Cook MB, Nakagawa H, Kraft P, Chanock SJ, Easton DF, Henderson BE, Coetzee GA, Conti DV, Haiman CA (2015) Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. Hum Mol Genet 24(19):5603–5618. doi:10.1093/hmg/ddv269, ddv269 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990) Family history and the risk of prostate cancer. Prostate 17(4):337–347

    Article  CAS  PubMed  Google Scholar 

  45. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T (1995) Family history and prostate cancer risk in Black, White, and Asian men in the United States and Canada. Am J Epidemiol 141(8):732–740

    CAS  PubMed  Google Scholar 

  46. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78–85. doi:10.1056/NEJM200007133430201

    Article  CAS  PubMed  Google Scholar 

  47. Xu J, Mo Z, Ye D, Wang M, Liu F, Jin G, Xu C, Wang X, Shao Q, Chen Z, Tao Z, Qi J, Zhou F, Wang Z, Fu Y, He D, Wei Q, Guo J, Wu D, Gao X, Yuan J, Wang G, Xu Y, Yao H, Dong P, Jiao Y, Shen M, Yang J, Ou-Yang J, Jiang H, Zhu Y, Ren S, Zhang Z, Yin C, Dai B, Hu Z, Yang Y, Wu Q, Chen H, Peng P, Zheng Y, Zheng X, Xiang Y, Long J, Gong J, Na R, Lin X, Yu H, Tao S, Feng J, Sun J, Liu W, Hsing A, Rao J, Ding Q, Wiklund F, Gronberg H, Shu XO, Zheng W, Shen H, Jin L, Shi R, Lu D, Zhang X, Zheng SL, Sun Y (2012) Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet 44(11):1231–1235. doi:10.1038/ng.2424, ng.2424 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N, Kawaguchi T, Tsunoda T, Inazawa J, Kamatani N, Ogawa O, Fujioka T, Nakamura Y, Nakagawa H (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 42(9):751–754. doi:10.1038/ng.635, ng.635 [pii]

    Article  CAS  PubMed  Google Scholar 

  49. Cheng I, Chen GK, Nakagawa H, He J, Wan P, Laurie CC, Shen J, Sheng X, Pooler LC, Crenshaw AT, Mirel DB, Takahashi A, Kubo M, Nakamura Y, Al Olama AA, Benlloch S, Donovan JL, Guy M, Hamdy FC, Kote-Jarai Z, Neal DE, Wilkens LR, Monroe KR, Stram DO, Muir K, Eeles RA, Easton DF, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA (2012) Evaluating genetic risk for prostate cancer among Japanese and Latinos. Cancer Epidemiol Biomarkers Prev 21(11):2048–2058. doi:10.1158/1055-9965.EPI-12-0598, 1055-9965.EPI-12-0598 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Platz EA, Giovannucci E (2004) The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92(4):237–253. doi:10.1016/j.jsbmb.2004.10.002, S0960-0760(04)00364-4 [pii]

    Article  CAS  PubMed  Google Scholar 

  51. Hsing AW (2001) Hormones and prostate cancer: what’s next? Epidemiol Rev 23(1):42–58

    Article  CAS  PubMed  Google Scholar 

  52. Roddam AW, Allen NE, Appleby P, Key TJ (2008) Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100(3):170–183. doi:10.1093/jnci/djm323, djm323 [pii]

    Article  CAS  PubMed  Google Scholar 

  53. Calistro Alvarado L (2010) Population differences in the testosterone levels of young men are associated with prostate cancer disparities in older men. Am J Hum Biol 22(4):449–455. doi:10.1002/ajhb.21016

    Article  PubMed  Google Scholar 

  54. Cheng I, Yu MC, Koh WP, Pike MC, Kolonel LN, Henderson BE, Stram DO (2005) Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States. Cancer Epidemiol Biomarkers Prev 14(7):1692–1696. doi:10.1158/1055-9965.EPI-04-0864, 14/7/1692 [pii]

    Article  CAS  PubMed  Google Scholar 

  55. Wu AH, Whittemore AS, Kolonel LN, Stanczyk FZ, John EM, Gallagher RP, West DW (2001) Lifestyle determinants of 5alpha-reductase metabolites in older African–American, White, and Asian–American men. Cancer Epidemiol Biomarkers Prev 10(5):533–538

    CAS  PubMed  Google Scholar 

  56. Heidegger I, Massoner P, Sampson N, Klocker H (2015) The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer. Cancer Lett 367(2):113–121. doi:10.1016/j.canlet.2015.07.026, S0304-3835(15)00481-4 [pii]

    Article  CAS  PubMed  Google Scholar 

  57. Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP (2008) Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Cancer Epidemiol Biomarkers Prev 17(1):252–254. doi:10.1158/1055-9965.EPI-07-2694, 17/1/252 [pii]

    Article  CAS  PubMed  Google Scholar 

  58. Gill JK, Wilkens LR, Pollak MN, Stanczyk FZ, Kolonel LN (2010) Androgens, growth factors, and risk of prostate cancer: the multiethnic cohort. Prostate 70(8):906–915. doi:10.1002/pros.21125

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. doi:10.1016/j.cell.2011.02.013, S0092-8674(11)00127-9 [pii]

    Article  CAS  PubMed  Google Scholar 

  60. Sutcliffe S (2010) Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses. Future Oncol 6(8):1289–1311. doi:10.2217/fon.10.95

    Article  PubMed  Google Scholar 

  61. Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE (2008) Epidemiology of prostatitis. Int J Antimicrob Agents 31(Suppl 1):S85–S90. doi:10.1016/j.ijantimicag.2007.08.028, S0924-8579(07)00552-3 [pii]

    Article  CAS  PubMed  Google Scholar 

  62. Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282(3):236–237, doi:jlt0721 [pii]

    Article  CAS  PubMed  Google Scholar 

  63. Jiang J, Li J, Yunxia Z, Zhu H, Liu J, Pumill C (2013) The role of prostatitis in prostate cancer: meta-analysis. PLoS One 8(12):e85179. doi:10.1371/journal.pone.0085179, PONE-D-13-36344 [pii]

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Lian WQ, Luo F, Song XL, Lu YJ, Zhao SC (2015) Gonorrhea and prostate cancer incidence: an updated meta-analysis of 21 epidemiologic studies. Med Sci Monit 21:1902–1910. doi:10.12659/MSM.893579, 893579 [pii]

    PubMed  Google Scholar 

  65. Caini S, Gandini S, Dudas M, Bremer V, Severi E, Gherasim A (2014) Sexually transmitted infections and prostate cancer risk: a systematic review and meta-analysis. Cancer Epidemiol 38(4):329–338. doi:10.1016/j.canep.2014.06.002, S1877-7821(14)00105-2 [pii]

    Article  PubMed  Google Scholar 

  66. Cheng I, Witte JS, Jacobsen SJ, Haque R, Quinn VP, Quesenberry CP, Caan BJ, Van Den Eeden SK (2010) Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men’s Health Study. PLoS One 5(1):e8736. doi:10.1371/journal.pone.0008736

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. World Cancer Research Fund International (2014) Continuous Update Project Report. Diet, nutrition, physical activity, and prostate cancer. World Cancer Research Fund International/American Institute for Cancer Research, London

    Google Scholar 

  68. Discacciati A, Orsini N, Wolk A (2012) Body mass index and incidence of localized and advanced prostate cancer—a dose–response meta-analysis of prospective studies. Ann Oncol 23(7):1665–1671. doi:10.1093/annonc/mdr603, mdr603 [pii]

    Article  CAS  PubMed  Google Scholar 

  69. Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Benichou J, Xie T, Gao YT (2000) Body size and prostate cancer: a population-based case–control study in China. Cancer Epidemiol Biomarkers Prev 9(12):1335–1341

    CAS  PubMed  Google Scholar 

  70. Habel LA, Van Den Eeden SK, Friedman GD (2000) Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate 43(2):136–143. doi:10.1002/(SICI)1097-0045(20000501)43:2<136::AID-PROS8>3.0.CO;2-L [pii]

    Article  CAS  PubMed  Google Scholar 

  71. Hernandez BY, Park SY, Wilkens LR, Henderson BE, Kolonel LN (2009) Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 18(9):2413–2421. doi:10.1158/1055-9965.EPI-09-0293, 1055-9965.EPI-09-0293 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  72. Severson RK, Grove JS, Nomura AM, Stemmermann GN (1988) Body mass and prostatic cancer: a prospective study. BMJ 297(6650):713–715

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S (2006) Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men. Br J Cancer 94(5):740–742. doi:10.1038/sj.bjc.6602983, 6602983 [pii]

    CAS  PubMed  PubMed Central  Google Scholar 

  74. Baillargeon J, Pollock BH, Kristal AR, Bradshaw P, Hernandez J, Basler J, Higgins B, Lynch S, Rozanski T, Troyer D, Thompson I (2005) The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103(5):1092–1095. doi:10.1002/cncr.20856

    Article  PubMed  Google Scholar 

  75. Grubb RL 3rd, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL Jr (2009) Serum prostate-specific antigen hemodilution among obese men undergoing screening in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 18(3):748–751. doi:10.1158/1055-9965.EPI-08-0938, 1055-9965.EPI-08-0938 [pii]

    Article  CAS  PubMed  Google Scholar 

  76. Zhang J, Sheng B, Ma M, Nan X (2015) An inverse association of body mass index and prostate-specific antigen in northwest men of China: a population-based analysis. Int J Clin Exp Med 8(3):4557–4562

    PubMed  PubMed Central  Google Scholar 

  77. Cao Y, Ma J (2011) Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 4(4):486–501. doi:10.1158/1940-6207.CAPR-10-0229, 1940-6207.CAPR-10-0229 [pii]

    Article  CAS  Google Scholar 

  78. Buschemeyer WC 3rd, Freedland SJ (2007) Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol 52(2):331–343. doi:10.1016/j.eururo.2007.04.069, S0302-2838(07)00664-1 [pii]

    Article  PubMed  Google Scholar 

  79. Chyou PH, Nomura AM, Stemmermann GN (1994) A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer 57(3):313–317

    Article  CAS  PubMed  Google Scholar 

  80. Park SY, Haiman CA, Cheng I, Park SL, Wilkens LR, Kolonel LN, Le Marchand L, Henderson BE (2015) Racial/ethnic differences in lifestyle-related factors and prostate cancer risk: the multiethnic cohort study. Cancer Causes Control 26(10):1507–1515. doi:10.1007/s10552-015-0644-y [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  81. Golabek T, Bukowczan J, Chlosta P, Powroznik J, Dobruch J, Borowka A (2014) Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies. Urol Int 92(1):7–14. doi:10.1159/000351325, 000351325 [pii]

    Article  CAS  PubMed  Google Scholar 

  82. Moyad MA (2002) Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective. Urology 59(4 Suppl 1):41–50, doi:S009042950101175X [pii]

    Article  PubMed  Google Scholar 

  83. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60(4):207–221. doi:10.3322/caac.20078, caac.20078 [pii]

    Article  PubMed  Google Scholar 

  84. Bansal D, Bhansali A, Kapil G, Undela K, Tiwari P (2013) Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies. Prostate Cancer Prostatic Dis 16(2):151–158. doi:10.1038/pcan.2012.40, S151pcan201240 [pii]

    CAS  PubMed  Google Scholar 

  85. Waters KM, Henderson BE, Stram DO, Wan P, Kolonel LN, Haiman CA (2009) Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 169(8):937–945. doi:10.1093/aje/kwp003, kwp003 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  86. Rastmanesh R, Hejazi J, Marotta F, Hara N (2014) Type 2 diabetes: a protective factor for prostate cancer? An overview of proposed mechanisms. Clin Genitourin Cancer 12(3):143–148. doi:10.1016/j.clgc.2014.01.001, S1558-7673(14)00002-0 [pii]

    Article  PubMed  Google Scholar 

  87. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP (2011) Preventable exposures associated with human cancers. J Natl Cancer Inst 103(24):1827–1839. doi:10.1093/jnci/djr483, djr483 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  88. Islami F, Moreira DM, Boffetta P, Freedland SJ (2014) A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol 66(6):1054–1064. doi:10.1016/j.eururo.2014.08.059, S0302-2838(14)00812-4 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  89. Bae JM, Li ZM, Shin MH, Kim DH, Lee MS, Ahn YO (2013) Cigarette smoking and prostate cancer risk: negative results of the Seoul Male Cancer Cohort Study. Asian Pac J Cancer Prev 14(8):4667–4669

    Article  PubMed  Google Scholar 

  90. Sawada N, Inoue M, Iwasaki M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S (2014) Alcohol and smoking and subsequent risk of prostate cancer in Japanese men: the Japan Public Health Center-based prospective study. Int J Cancer 134(4):971–978. doi:10.1002/ijc.28423

    Article  CAS  PubMed  Google Scholar 

  91. Butler LM, Wang R, Wong AS, Koh WP, Yu MC (2009) Cigarette smoking and risk of prostate cancer among Singapore Chinese. Cancer Causes Control 20(10):1967–1974. doi:10.1007/s10552-009-9391-2

    Article  PubMed  Google Scholar 

  92. Rohrmann S, Linseisen J, Allen N, Bueno-de-Mesquita HB, Johnsen NF, Tjonneland A, Overvad K, Kaaks R, Teucher B, Boeing H, Pischon T, Lagiou P, Trichopoulou A, Trichopoulos D, Palli D, Krogh V, Tumino R, Ricceri F, Arguelles Suarez MV, Agudo A, Sanchez MJ, Chirlaque MD, Barricarte A, Larranaga N, Boshuizen H, van Kranen HJ, Stattin P, Johansson M, Bjartell A, Ulmert D, Khaw KT, Wareham NJ, Ferrari P, Romieux I, Gunter MJ, Riboli E, Key TJ (2013) Smoking and the risk of prostate cancer in the European Prospective Investigation into cancer and nutrition. Br J Cancer 108(3):708–714. doi:10.1038/bjc.2012.520, bjc2012520 [pii]

    Article  CAS  PubMed  Google Scholar 

  93. Rolison JJ, Hanoch Y, Miron-Shatz T (2012) Smokers: at risk for prostate cancer but unlikely to screen. Addict Behav 37(6):736–738. doi:10.1016/j.addbeh.2012.02.006, S0306-4603(12)00059-7 [pii]

    Article  PubMed  Google Scholar 

  94. Nomura AM, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 9(9):883–887

    CAS  PubMed  Google Scholar 

  95. Huang M, Narita S, Numakura K, Tsuruta H, Saito M, Inoue T, Horikawa Y, Tsuchiya N, Habuchi T (2012) A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling. Prostate 72(16):1779–1788. doi:10.1002/pros.22531

    Article  CAS  PubMed  Google Scholar 

  96. Kolonel LN, Hankin JH, Lee J, Chu SY, Nomura AM, Hinds MW (1981) Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 44(3):332–339

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Kolonel LN, Hankin JH, Nomura AM, Chu SY (1981) Dietary fat intake and cancer incidence among five ethnic groups in Hawaii. Cancer Res 41(9 Pt 2):3727–3728

    CAS  PubMed  Google Scholar 

  98. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS (2008) Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev 17(4):930–937. doi:10.1158/1055-9965.EPI-07-2681, 17/4/930 [pii]

    Article  CAS  PubMed  Google Scholar 

  99. Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN (2007) Fat and meat intake and prostate cancer risk: the multiethnic cohort study. Int J Cancer 121(6):1339–1345. doi:10.1002/ijc.22805

    Article  CAS  PubMed  Google Scholar 

  100. Park SY, Wilkens LR, Henning SM, Le Marchand L, Gao K, Goodman MT, Murphy SP, Henderson BE, Kolonel LN (2009) Circulating fatty acids and prostate cancer risk in a nested case–control study: the multiethnic cohort. Cancer Causes Control 20(2):211–223. doi:10.1007/s10552-008-9236-4

    Article  PubMed  Google Scholar 

  101. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L (1997) Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 71(4):545–551. doi:10.1002/(SICI)1097-0215(19970516)71:4<545::AID-IJC7>3.0.CO;2-U [pii]

    Article  CAS  PubMed  Google Scholar 

  102. Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, Johnsen NF, Tjonneland A, Linseisen J, Kaaks R, Boeing H, Kroger J, Trichopoulou A, Zavitsanou A, Trichopoulos D, Sacerdote C, Palli D, Tumino R, Agnoli C, Kiemeney LA, Bueno-de-Mesquita HB, Chirlaque MD, Ardanaz E, Larranaga N, Quiros JR, Sanchez MJ, Gonzalez CA, Stattin P, Hallmans G, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ (2008) Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case–control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88(5):1353–1363, doi:88/5/1353 [pii]

    CAS  PubMed  Google Scholar 

  103. Bassett JK, Severi G, Hodge AM, MacInnis RJ, Gibson RA, Hopper JL, English DR, Giles GG (2013) Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer 133(8):1882–1891. doi:10.1002/ijc.28203

    Article  CAS  PubMed  Google Scholar 

  104. Sharma S, Cao X, Wilkens LR, Yamamoto J, Lum-Jones A, Henderson BE, Kolonel LN, Le Marchand L (2010) Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 19(7):1866–1870. doi:10.1158/1055-9965.EPI-10-0231, 1055-9965.EPI-10-0231 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS Jr (2000) Vegetables, fruits, legumes and prostate cancer: a multiethnic case–control study. Cancer Epidemiol Biomarkers Prev 9(8):795–804

    CAS  PubMed  Google Scholar 

  106. Stram DO, Hankin JH, Wilkens LR, Park S, Henderson BE, Nomura AM, Pike MC, Kolonel LN (2006) Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States). Cancer Causes Control 17(9):1193–1207. doi:10.1007/s10552-006-0064-0

    Article  PubMed  Google Scholar 

  107. Akaza H (2012) Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the “second human genome”. Cancer Sci 103(6):969–975. doi:10.1111/j.1349-7006.2012.02257.x

    Article  CAS  PubMed  Google Scholar 

  108. Mahmoud AM, Yang W, Bosland MC (2014) Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol 140:116–132. doi:10.1016/j.jsbmb.2013.12.010, S0960-0760(13)00283-5 [pii]

    Article  CAS  PubMed  Google Scholar 

  109. Yan L, Spitznagel EL (2005) Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 117(4):667–669. doi:10.1002/ijc.21266

    Article  CAS  PubMed  Google Scholar 

  110. Yan L, Spitznagel EL (2009) Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89(4):1155–1163. doi:10.3945/ajcn.2008.27029, ajcn.2008.27029 [pii]

    Article  CAS  PubMed  Google Scholar 

  111. Nomura AM, Hankin JH, Lee J, Stemmermann GN (2004) Cohort study of tofu intake and prostate cancer: no apparent association. Cancer Epidemiol Biomarkers Prev 13(12):2277–2279, doi:13/12/2277 [pii]

    PubMed  Google Scholar 

  112. Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN (2008) Legume and isoflavone intake and prostate cancer risk: the multiethnic cohort study. Int J Cancer 123(4):927–932. doi:10.1002/ijc.23594

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Park SY, Wilkens LR, Franke AA, Le Marchand L, Kakazu KK, Goodman MT, Murphy SP, Henderson BE, Kolonel LN (2009) Urinary phytoestrogen excretion and prostate cancer risk: a nested case–control study in the multiethnic cohort. Br J Cancer 101(1):185–191. doi:10.1038/sj.bjc.6605137, 6605137 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Mandair D, Rossi RE, Pericleous M, Whyand T, Caplin ME (2014) Prostate cancer and the influence of dietary factors and supplements: a systematic review. Nutr Metab (Lond) 11:30. doi:10.1186/1743-7075-11-30, 1743-7075-11-30 [pii]

    Article  CAS  Google Scholar 

  115. Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9(6):429–439. doi:10.1038/nrc2641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Park SY, Murphy SP, Wilkens LR, Stram DO, Henderson BE, Kolonel LN (2007) Calcium, vitamin D, and dairy product intake and prostate cancer risk: the multiethnic cohort study. Am J Epidemiol 166(11):1259–1269. doi:10.1093/aje/kwm269, kwm269 [pii]

    Article  PubMed  Google Scholar 

  117. Nomura AM, Stemmermann GN, Lee J, Kolonel LN, Chen TC, Turner A, Holick MF (1998) Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States). Cancer Causes Control 9(4):425–432

    Article  CAS  PubMed  Google Scholar 

  118. Nomura AM, Stemmermann GN, Lee J, Craft NE (1997) Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 6(7):487–491

    CAS  PubMed  Google Scholar 

  119. Park SY, Wilkens LR, Morris JS, Henderson BE, Kolonel LN (2013) Serum zinc and prostate cancer risk in a nested case–control study: the multiethnic cohort. Prostate 73(3):261–266. doi:10.1002/pros.22565

    Article  CAS  PubMed  Google Scholar 

  120. Gill JK, Franke AA, Steven Morris J, Cooney RV, Wilkens LR, Le Marchand L, Goodman MT, Henderson BE, Kolonel LN (2009) Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control 20(7):1161–1171. doi:10.1007/s10552-009-9304-4

    Article  PubMed  PubMed Central  Google Scholar 

  121. Park SY, Cooney RV, Wilkens LR, Murphy SP, Henderson BE, Kolonel LN (2010) Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort. Eur J Cancer 46(5):932–936. doi:10.1016/j.ejca.2009.12.030, S0959-8049(09)00961-7 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Aune D, Navarro Rosenblatt DA, Chan DS, Vieira AR, Vieira R, Greenwood DC, Vatten LJ, Norat T (2015) Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies. Am J Clin Nutr 101(1):87–117. doi:10.3945/ajcn.113.067157, ajcn.113.067157 [pii]

    Article  CAS  PubMed  Google Scholar 

  123. Pollack ES, Nomura AM, Heilbrun LK, Stemmermann GN, Green SB (1984) Prospective study of alcohol consumption and cancer. N Engl J Med 310(10):617–621. doi:10.1056/NEJM198403083101003

    Article  CAS  PubMed  Google Scholar 

  124. Kolonel LN, Yoshizawa C, Nomura AM, Stemmermann GN (1994) Relationship of serum uric acid to cancer occurrence in a prospective male cohort. Cancer Epidemiol Biomarkers Prev 3(3):225–228

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Financial Disclosure: None.

Authors’ declaration of personal interests: None declared.

Declaration of funding interests: None declared.

Author information

Authors and Affiliations

  1. Cancer Prevention Institute of California, 2201 Walnut Avenue, Suite 300, Fremont, CA, 94538, US

    Shannon M. Conroy, Scarlett Lin Gomez & Iona Cheng

  2. Cancer Epidemiology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, 96813, HI, US

    Song-Yi Park

Authors
  1. Shannon M. Conroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Song-Yi Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scarlett Lin Gomez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Iona Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iona Cheng .

Editor information

Editors and Affiliations

  1. Department of Preventive Medicine, Keck School of Medicine of USC University of Southern California, Los Angeles, California, USA

    Anna H. Wu

  2. Department of Preventive Medicine, Keck School of Medicine of USC University of Southern California, Los Angeles, California, USA

    Daniel O. Stram

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Conroy, S.M., Park, SY., Gomez, S.L., Cheng, I. (2016). Prostate Cancer Among Asian Americans. In: Wu, A., Stram, D. (eds) Cancer Epidemiology Among Asian Americans. Springer, Cham. https://doi.org/10.1007/978-3-319-41118-7_7

Download citation

Publish with us

Policies and ethics

Search

Navigation